CL2017003442A1 - Composiciones y métodos para modular y/o estimular respuestas inmunes en humanos y/o animales - Google Patents

Composiciones y métodos para modular y/o estimular respuestas inmunes en humanos y/o animales

Info

Publication number
CL2017003442A1
CL2017003442A1 CL2017003442A CL2017003442A CL2017003442A1 CL 2017003442 A1 CL2017003442 A1 CL 2017003442A1 CL 2017003442 A CL2017003442 A CL 2017003442A CL 2017003442 A CL2017003442 A CL 2017003442A CL 2017003442 A1 CL2017003442 A1 CL 2017003442A1
Authority
CL
Chile
Prior art keywords
animals
modulate
humans
compositions
methods
Prior art date
Application number
CL2017003442A
Other languages
English (en)
Inventor
Castex Mathieu
Original Assignee
Danstar Ferment Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danstar Ferment Ag filed Critical Danstar Ferment Ag
Publication of CL2017003442A1 publication Critical patent/CL2017003442A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Insects & Arthropods (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

<p>SE PROPORCIONA UNA COMPOSICIÓN QUE COMPRENDE POLISACÁRIDOS PARIETALES DE AL MENOS UNA ESPECIE DE CANDIDA Y POLISACÁRIDOS PARIETALES DE AL MENOS UNA ESPECIE DE LEVADURA DIFERENTE. LA COMPOSICIÓN PUEDE UTILIZARSE EN LA MODULACIÓN Y!O ESTIMULACIÓN DE RESPUESTAS INMUNES EN ANIMALES Y HUMANOS.</p>
CL2017003442A 2015-07-09 2017-12-28 Composiciones y métodos para modular y/o estimular respuestas inmunes en humanos y/o animales CL2017003442A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15176029.5A EP3138573A1 (en) 2015-07-09 2015-07-09 Compositions and methods for stimulating immune responses in human and/or animal

Publications (1)

Publication Number Publication Date
CL2017003442A1 true CL2017003442A1 (es) 2018-07-13

Family

ID=53776303

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017003442A CL2017003442A1 (es) 2015-07-09 2017-12-28 Composiciones y métodos para modular y/o estimular respuestas inmunes en humanos y/o animales

Country Status (12)

Country Link
US (1) US11338023B2 (es)
EP (2) EP3138573A1 (es)
JP (2) JP7252758B2 (es)
CN (2) CN107847536A (es)
AU (1) AU2016289523B2 (es)
BR (1) BR112018000102B1 (es)
CL (1) CL2017003442A1 (es)
DK (1) DK3319621T3 (es)
ES (1) ES2953462T3 (es)
HU (1) HUE063641T2 (es)
PL (1) PL3319621T3 (es)
WO (1) WO2017005936A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3935581A4 (en) 2019-03-04 2022-11-30 Iocurrents, Inc. DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING
WO2023220275A1 (en) * 2022-05-12 2023-11-16 Can Technologies, Inc. Compositions and methods for the treatment and prevention of coccidiosis infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506210A (en) * 1988-08-19 1996-04-09 The Australian National University Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
CA2040374C (en) * 1990-07-06 1998-06-16 Gunnar Rorstad Process for enhancing the resistance of aquatic animals to disease
FR2726284B1 (fr) 1994-10-31 1996-12-27 Inst Oenologie Produit biologique pour la stabilisation physico-chimique d'un vin
US6214337B1 (en) * 1995-04-18 2001-04-10 Biotec Asa Animal feeds comprising yeast glucan
US20030235569A1 (en) 2002-06-18 2003-12-25 Ling Yuk Cheung Feed additives for chickens
US8992999B2 (en) 2004-06-25 2015-03-31 Alltech, Inc. Methods and compositions for controlling parasitic infections of animals
JP2009203160A (ja) * 2006-05-25 2009-09-10 Saihatsu Ko 抗ウィルス及び抗菌剤
EP2137292B1 (en) 2007-04-20 2019-05-22 Rymco International AG Peptide mixture as wine stabiliser
CN102228138B (zh) * 2011-06-04 2013-01-16 内蒙古农业大学 一种反刍动物微生态添加剂及其制备工艺

Also Published As

Publication number Publication date
BR112018000102B1 (pt) 2021-10-05
DK3319621T3 (da) 2023-08-21
EP3319621A1 (en) 2018-05-16
JP2021183608A (ja) 2021-12-02
WO2017005936A9 (en) 2017-03-09
BR112018000102A2 (pt) 2018-09-04
CN107847536A (zh) 2018-03-27
JP7252758B2 (ja) 2023-04-05
US20180207248A1 (en) 2018-07-26
AU2016289523A1 (en) 2018-01-18
US11338023B2 (en) 2022-05-24
HUE063641T2 (hu) 2024-01-28
WO2017005936A1 (en) 2017-01-12
JP7291749B2 (ja) 2023-06-15
PL3319621T3 (pl) 2023-10-09
AU2016289523B2 (en) 2022-07-14
ES2953462T3 (es) 2023-11-13
EP3138573A1 (en) 2017-03-08
CA2990530A1 (en) 2017-01-12
CN119770515A (zh) 2025-04-08
EP3319621B1 (en) 2023-06-07
JP2018522001A (ja) 2018-08-09

Similar Documents

Publication Publication Date Title
CO2019006291A2 (es) Composiciones de aminoácidos y métodos de tratamiento de enfermedades hepáticas
IL261884B (en) Compositions of natural extracts and use thereof in methods for preventing or treating diseases
EP3926040A4 (en) Multi-lactobacillus composition and application thereof to vaginal health of females
EA201800591A1 (ru) Микрокапсулы, содержащие живые микроорганизмы, и их применение
CL2017001464A1 (es) Modulación inmunológica
MX2018016078A (es) Composiciones que comprenden cepas bacterianas.
MX389718B (es) Formulaciones y metodos de tratamiento con queratina.
BR112017008726A2 (pt) usos de um extrato de fermento e de um exopolissacarídeo, e, composição cosmética.
MX2022008663A (es) Composiciones alergenicas mixtas y metodos de uso de las mismas.
MA51107A (fr) Cellules souches et progénitrices hématopoïétiques humaines cd34+ modifiées par crispr-cas9 et utilisations associées
MX2018000870A (es) Metodos y materiales para mejorar las respuestas inmunitarias y funciones de la barrera de piel y/o mucosa.
PE20171076A1 (es) Composicion que contiene quitina y proteinas digeribles
CL2019002641A1 (es) Composiciones y métodos que involucran moléculas probióticas.
CL2018000963A1 (es) Cosmética que tiene bacterias probióticas
BR112017010711A2 (pt) formulações bioestimulantes/reguladoras de crescimento de vegetais e colheitas e métodos de uso
MX2018013184A (es) Composiciones de saponinas y extractos vegetales.
CO2020006907A2 (es) Péptidos antimicrobianos y métodos para usarlos
EA202091226A1 (ru) Применение лигниновой фракции в качестве ингредиента пищевой добавки для человека и животных
PL3764790T3 (pl) Zastosowanie formulacji tanin przeciwko chorobom bakteryjnym i grzybowym u roślin
MX2019005661A (es) Método para tratar la psoriasis con el anticuerpo específico anti-il23.
CO2018012180A2 (es) Métodos de tratamiento para enfermedades colestásicas y fibróticas
EP3781179A4 (en) HUMAN SEA KYNURENINA ENZYMES AND USES THEREOF
MX392976B (es) Composiciones que comprenden cepas bacterianas.
CL2017003442A1 (es) Composiciones y métodos para modular y/o estimular respuestas inmunes en humanos y/o animales
BR112016028561A8 (pt) composição e forma de dosagem compreendendo um óleo marinho que compreende ácidos graxos, e, uso das mesmas